tRNA dosage regulates lineage dependency and resistance in prostate cancer

By afschroeder • October 8, 2026

Kim YS, Arora S, Young D, Tsou A, Shiuan A, Wladyka CL, Rudoy D, Kim JY, Waters JA, Schuster SL, Coleman IM, Kapur M, Sobczyk M, Katanski CD, Bayat Tork AM, Zhang W, Nelson PS, Ha G, Haffner MC, Corey E, Morrissey C, Wang Y, Subramaniam AR, Lee JK, Ackerman SL, Pan T, Hsieh AC. tRNA dosage regulates lineage dependency and resistance in prostate cancer. Nature. 2026 Oct 7. doi: 10.1038/s41586-026-11153-8. Epub ahead of print. PMID: 42844465.

Tags: Hematology/Oncology, Publications

Androgen receptor inhibitor double therapies in the management of metastatic castration-sensitive prostate cancer: a cost-effectiveness analysis

Padula WV, Cohen BG, Steel P, Appukkuttan S, Kalayeh B, Rettig M. Androgen receptor inhibitor double therapies in the management of metastatic castration-sensitive prostate cancer:[...]

Rethinking the possibilities of adult ring sideroblastic anaemia

Carlson SG, Koo M, Dommaraju S, Song AH, Chai-Ho W. Rethinking the possibilities of adult ring sideroblastic anaemia. Lancet Haematol. 2026 Oct 6:S2352-3026(26)00133-X. doi: 10.1016/S2352-3026(26)00133-X.[...]

Topoisomerase-Based CDH17 Antibody Drug Conjugates Overcome P-gp Resistance but Undergo Target Mediated Clearance in Colorectal Cancer

O'Brien NA, Zhang J, Gong KW, McDermott MSJ, Hoffstrom B, Lu M, Liang M, Jia WP, Luo T, Madrid AM, Ayala R, Presta L, Larson[...]